Hosein, Abdel Nasser http://orcid.org/0000-0003-1567-6700
Dougan, Stephanie K. http://orcid.org/0000-0002-2263-363X
Aguirre, Andrew J. http://orcid.org/0000-0002-0701-6203
Maitra, Anirban http://orcid.org/0000-0001-7923-9978
Article History
Received: 26 June 2021
Accepted: 23 February 2022
First Online: 29 March 2022
Competing interests
: A.N.H. has no disclosures. S.K.D. receives grant funding from Novartis, BMS, Genocea and Eli Lilly and is a cofounder and SAB member of Kojin Therapeutics. A.J.A. has consulted for Oncorus, Inc., Arrakis Therapeutics, Syros Pharmaceuticals, Boehringer Ingelheim, T-knife Therapeutics, AstraZeneca, Mirati Therapeutics and Merck & Co., Inc., and has research funding from Mirati Therapeutics, Syros Pharmaceuticals, Revolution Medicines, Novartis, Bristol Myers Squibb, Deerfield, Inc., and Novo Ventures that is unrelated to this work. A.M. receives royalties for a pancreatic cancer biomarker test from Cosmos Wisdom Biotechnology, is listed as an inventor on a patent that has been licensed by Johns Hopkins University to ThriveEarlier Detection and serves as a consultant for Freenome and Tezcat Biotechnology.
Free to read: This content has been made available to all.